ASX: ACW - Xanamem Clinical Development & Investor Update.

Tuesday, July 2, 2019 10:00 PM +00:00

ASX: ACW - Xanamem Clinical Development & Inv...0:0010:09
LIVEQuality1  AudioSubtitleDownloadSpeed1  
ACTINOGEN LIMITED
Bill Ketelbey

Actinogen Medical (ASX: ACW) is pleased to provide an update on the progress the Company is making with the ongoing clinical development program for Xanamem™. This update should be read in conjunction with the latest investor presentation.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 4 Nov

    00:00

    Third Quarter 2019 Earnings Call November 1, 2019

    EXXON MOBIL CORPORATION
  • 4 Nov

    00:00

    Investor Presentation - Takeover offer for Panoramic Resources Limited

    INDEPENDENCE GROUP NL
  • 4 Nov

    01:00

    Q3 2019 American International Group, Inc. Earnings Conference Call 01 November 2019

    AMERICAN INTERNATIONAL GROUP
  • 4 Nov

    01:00

    Seagate Technology Fiscal First Quarter 2020 Conference Call 01 November 2019

    SEAGATE TECHNOLOGY PLC
  • 4 Nov

    02:00

    Dominion Energy Third Quarter 2019 Earnings Conference Call 01 November 2019

    DOMINION ENERGY INC